IL-6,IL-10和CRP在胃肠道癌症中的作用
Reyhaneh Yarmohammadi1, Kazem Najafi2, Mina Noroozbeygi3
1Department of Pharmaceutical Sciences, School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, Maryland, USA.
Cell biology international
|July 1, 2025
概括
介质素-6 (IL-6),介质素-10 (IL-10) 和C反应蛋白 (CRP) 是胃肠 (GI) 癌症进展和治疗反应的生物标志物. 了解这些炎症标志物可以改善胃肠道癌症的诊断和治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 胃肠道 (GI) 癌症对全球健康构成重大挑战.
- 介质素-6 (IL-6),介质素-10 (IL-10) 和C反应蛋白 (CRP) 是关键的炎症调解剂,与癌症有关.
- 了解它们在肠道癌症中的作用对于推进患者护理至关重要.
研究的目的:
- 研究IL-6,IL-10和CRP之间的关系以及肠胃癌的发病因子.
- 评估这些标记物作为诊断和预后工具的潜力.
- 探索它们对化疗敏感性的影响以及它们在化疗预防中的作用.
主要方法:
- 对IL-6,IL-10和CRP在各种胃肠道癌症 (食道癌,胃癌,胰腺癌,肝胆癌,结肠直肠癌) 的最新研究的综述.
- 分析标志物水平与疾病阶段,预后和治疗反应之间的关联.
- 探索它们在癌症发展中的参与以及作为治疗点的潜力.
主要成果:
- 升高的IL-6,IL-10和CRP水平与晚期肠胃癌阶段和更差的预后相关.
- 这些标记物可以预测治疗反应,调节化疗敏感度.
- IL-6,IL-10和CRP与肠道癌发育和进展的分子机制有关.
结论:
- IL-6,IL-10和CRP显示出作为GI癌症诊断,预后和预测治疗结果的生物标志物的巨大潜力.
- 针对这些炎症途径可能为胃肠道癌症的预防和治疗提供新的策略.
- 需要进一步的研究,以将这些发现转化为管理肠道恶性瘤的临床应用.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
239
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
239
01:30Inflammatory Bowel Disease II: Crohn's Disease
399
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
399
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
01:17Chronic Bowel Disorders: Introduction
542
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
542
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
342
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
342
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277